The drugmaker said Thursday that it plans to submit its potential treatment donanemab to the Food and Drug Administration later this year.
U.S. drugmaker Lilly to submit ‘breakthrough’ Alzheimer’s drug to FDA
© The Crystal Eyes
The drugmaker said Thursday that it plans to submit its potential treatment donanemab to the Food and Drug Administration later this year.
© The Crystal Eyes